{"schema_version":"secwatch.filing_event.v1","accession":"0001654954-23-008880","form_type":"8-K","ticker":"ZIVO","cik":"0001101026","company_name":"Zivo Bioscience, Inc.","filed_at":"2023-07-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:33.141232+00:00","generated_at":"2026-06-13T11:34:49.306031+00:00","sec_items":["1.01","3.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"ZIVO Bioscience raises ~$4.0M in registered direct offering and concurrent private placement","bullets":["Sold 1,498,130 shares/pre-funded warrants at $2.67/unit to institutional investor for ~$4.0M gross proceeds.","Concurrent private placement of Series A (2-yr) and Series B (5-yr) warrants exercisable for 1,498,130 shares each at $2.80.","Offering expected to close July 5, 2023; Maxim Group LLC is sole placement agent.","Shares offered under effective S-3 registration; warrants unregistered under Section 4(a)(2)."],"urls":{"canonical":"https://secwatch.observer/filing/0001654954-23-008880","json":"https://secwatch.observer/filing/0001654954-23-008880.json","markdown":"https://secwatch.observer/filing/0001654954-23-008880.md","text":"https://secwatch.observer/filing/0001654954-23-008880.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1101026/000165495423008880/0001654954-23-008880-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1101026/000165495423008880/zivo_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T11:34:49.306031+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"afc1c4614d5260b45c8a542603b01167d520f13b","claim":"Zivo Bioscience, Inc. entered into Placement Agent Agreement with Maxim Group LLC valued at 7.0% of the gross proceeds (effective 2023-06-30).","evidence_excerpt":"On June 30, 2023, the Company entered into a placement agency agreement (the “Placement Agent Agreement”) with Maxim Group LLC (the “Placement Agent”) pursuant to which the Company engaged Maxim as the placement agent in connection with the Offerings.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1101026/000165495423008880/0001654954-23-008880-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"underwriting"},{"label":"Counterparty","value":"Maxim Group LLC"},{"label":"Value","value":"7.0% of the gross proceeds"},{"label":"Effective","value":"2023-06-30"}],"fact_type":"material_agreement"},{"claim_id":"c64f99fc165de1cef970c83ff8b55034d286d363","claim":"Zivo Bioscience, Inc. entered into Securities Purchase Agreement with a single institutional investor valued at aggregate gross proceeds from the Registered Offering of approximately $4.0 million (effective 2023-06-30).","evidence_excerpt":"On June 30, 2023, Zivo Biosciences, Inc., a Nevada corporation (the “Company”), entered into a Securities Purchase Agreement (the “Purchase Agreement”) with a single institutional investor named therein (the “Investor”), pursuant to which the Company agreed to issue and sell, in a registered direct offering by the Company directly to the Investor (the “Registered Offering”), (i) an aggregate of 1,030,000 shares (the “Shares”) of common stock, par value $0.001 per share, of the Company (“Common Stock”), at an offering price of $2.67 per share and (ii) an aggregate of 468,130 pre-funded warrants exercisable for shares of Common Stock (the “Pre-Funded Warrants”) at an offering price of $2.6699 per Pre-Funded Warrant, for aggregate gross proceeds from the Registered Offering of approximately $4.0 million before deducting the Placement Agent’s fee and related offering expenses.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1101026/000165495423008880/0001654954-23-008880-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"a single institutional investor"},{"label":"Value","value":"aggregate gross proceeds from the Registered Offering of approximately $4.0 million"},{"label":"Effective","value":"2023-06-30"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}